Skip to main content
Erschienen in: European Journal of Nutrition 6/2018

08.11.2017 | Review

Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis

verfasst von: Saman Khalesi, David Wayne Johnson, Katrin Campbell, Susan Williams, Andrew Fenning, Sonia Saluja, Christopher Irwin

Erschienen in: European Journal of Nutrition | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The gut–liver interaction suggests that modification of gut bacterial flora using probiotics and synbiotics may improve liver function. This systematic review and meta-analysis aimed to clarify the effect of probiotics and synbiotics consumption on the serum concentration of liver function enzymes.

Methods

PubMed (MEDLINE), Cumulative Index to Nursing and Allied Health Literature, and Cochrane Library (Central) were searched from 1980 to August 2017 for studies where adults consumed probiotics and/or synbiotics in controlled trials and changes in liver function enzymes were examined.

Results

A total of 17 studies (19 trials) were included in the meta-analysis. Random effects meta-analyses were applied. Probiotics and synbiotics significantly reduced serum alanine aminotransferase [− 8.05 IU/L, 95% confidence interval (CI) − 13.07 to − 3.04; p = 0.002]; aspartate aminotransferase (− 7.79 IU/L, 95% CI: − 13.93 to − 1.65; p = 0.02) and gamma-glutamyl transpeptidase (− 8.40 IU/L, 95% CI − 12.61 to − 4.20; p < 0.001). Changes in the serum concentration of alkaline phosphatase and albumin did not reach a statistically significant level. Changes to bilirubin levels were in favour of the control group (0.95 μmol/L, 95% CI 0.48–1.42; p < 0.001). Subgroup analysis suggested the existence of liver disease at baseline, synbiotics supplementation and duration of supplementation ≥ 8 weeks resulted in more pronounced improvement in liver function enzymes than their counterparts.

Conclusions

Probiotics and synbiotics may be suggested as supplements to improve serum concentration of liver enzymes, especially when synbiotics administered for a period ≥ 8 weeks and in individuals with liver disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A (2015) The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol Res Curr Rev 37 (2): 223–236 Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A (2015) The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol Res Curr Rev 37 (2): 223–236
6.
Zurück zum Zitat Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, Wang Y, Zhu B, Li L (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562–572. doi:10.1002/hep.24423 CrossRefPubMed Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, Wang Y, Zhu B, Li L (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562–572. doi:10.​1002/​hep.​24423 CrossRefPubMed
8.
Zurück zum Zitat Liu J, Wu D, Ahmed A, Li X, Ma Y, Tang L, Mo D, Ma Y, Xin Y (2012) Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals. Curr Microbiol 65(1):7–13. doi:10.1007/s00284-012-0105-8 CrossRefPubMed Liu J, Wu D, Ahmed A, Li X, Ma Y, Tang L, Mo D, Ma Y, Xin Y (2012) Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals. Curr Microbiol 65(1):7–13. doi:10.​1007/​s00284-012-0105-8 CrossRefPubMed
9.
Zurück zum Zitat Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Cales P, Diehl AM (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63(3):764–775. doi:10.1002/hep.28356 CrossRefPubMed Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Cales P, Diehl AM (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63(3):764–775. doi:10.​1002/​hep.​28356 CrossRefPubMed
10.
Zurück zum Zitat Gkolfakis P, Dimitriadis G, Triantafyllou K (2015) Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int HBPD INT 14(6):572–581CrossRefPubMed Gkolfakis P, Dimitriadis G, Triantafyllou K (2015) Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int HBPD INT 14(6):572–581CrossRefPubMed
11.
Zurück zum Zitat Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57(2):601–609. doi:10.1002/hep.26093 CrossRefPubMed Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57(2):601–609. doi:10.​1002/​hep.​26093 CrossRefPubMed
12.
Zurück zum Zitat Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50(11):2374–2383. doi:10.1007/s00125-007-0791-0 CrossRefPubMed Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50(11):2374–2383. doi:10.​1007/​s00125-007-0791-0 CrossRefPubMed
14.
Zurück zum Zitat Pereira DI, Gibson GR (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68(9):4689–4693CrossRefPubMedPubMedCentral Pereira DI, Gibson GR (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68(9):4689–4693CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Rodes L, Khan A, Paul A, Coussa-Charley M, Marinescu D, Tomaro-Duchesneau C, Shao W, Kahouli I, Prakash S (2013) Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J Microbiol Biotechnol 23(4):518 – 26CrossRefPubMed Rodes L, Khan A, Paul A, Coussa-Charley M, Marinescu D, Tomaro-Duchesneau C, Shao W, Kahouli I, Prakash S (2013) Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J Microbiol Biotechnol 23(4):518 – 26CrossRefPubMed
16.
Zurück zum Zitat Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121(3):580–591CrossRefPubMed Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121(3):580–591CrossRefPubMed
17.
18.
Zurück zum Zitat Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, Puri P, Sterling RK, Luketic V, Stravitz RT, Siddiqui MS, Fuchs M, Thacker LR, Wade JB, Daita K, Sistrun S, White MB, Noble NA, Thorpe C, Kakiyama G, Pandak WM, Sikaroodi M, Gillevet PM (2014) Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 39(10):1113–1125. doi:10.1111/apt.12695 CrossRefPubMedPubMedCentral Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, Puri P, Sterling RK, Luketic V, Stravitz RT, Siddiqui MS, Fuchs M, Thacker LR, Wade JB, Daita K, Sistrun S, White MB, Noble NA, Thorpe C, Kakiyama G, Pandak WM, Sikaroodi M, Gillevet PM (2014) Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 39(10):1113–1125. doi:10.​1111/​apt.​12695 CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A (2014) Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr 99(3):535–542. doi:10.3945/ajcn.113.068890 CrossRefPubMed Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A (2014) Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr 99(3):535–542. doi:10.​3945/​ajcn.​113.​068890 CrossRefPubMed
20.
Zurück zum Zitat Sang Hak H, Ki Tae S, Dong Joon K, Moon Young K, Soon Koo B, Young Don K, Gab Jin C, Dae Hee C, Young Lim H, Dong Hoon S, Eun Ji K, Han SH, Suk KT, Kim DJ, Kim MY, Baik SK, Kim YD, Cheon GJ, Choi DH, Ham YL (2015) Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol 27(11):1300–1306. doi:10.1097/MEG.0000000000000458 CrossRef Sang Hak H, Ki Tae S, Dong Joon K, Moon Young K, Soon Koo B, Young Don K, Gab Jin C, Dae Hee C, Young Lim H, Dong Hoon S, Eun Ji K, Han SH, Suk KT, Kim DJ, Kim MY, Baik SK, Kim YD, Cheon GJ, Choi DH, Ham YL (2015) Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol 27(11):1300–1306. doi:10.​1097/​MEG.​0000000000000458​ CrossRef
21.
Zurück zum Zitat Khalesi S, Sun J, Buys N, Jayasinghe R (2014) Effect of probiotics on blood pressure a systematic review and meta-analysis of randomized, controlled Trials. Hypertension 64(4):897–903CrossRefPubMed Khalesi S, Sun J, Buys N, Jayasinghe R (2014) Effect of probiotics on blood pressure a systematic review and meta-analysis of randomized, controlled Trials. Hypertension 64(4):897–903CrossRefPubMed
22.
Zurück zum Zitat Menaa F Are Probiotics Pro-Obesity or Potential Anti-Obesity Agents?(2015) J Food Nutr Sci 2 (1): 1 Menaa F Are Probiotics Pro-Obesity or Potential Anti-Obesity Agents?(2015) J Food Nutr Sci 2 (1): 1
23.
Zurück zum Zitat FAO/WHO (2002) Guidelines for the evaluation of probiotics in food, vol 30. World Health Organization, London, Ontario, Canada FAO/WHO (2002) Guidelines for the evaluation of probiotics in food, vol 30. World Health Organization, London, Ontario, Canada
24.
Zurück zum Zitat Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM, Vaneechoutte M, Van Loo J, Wolvers DA (2007) Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 65(11):469–489CrossRefPubMed Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM, Vaneechoutte M, Van Loo J, Wolvers DA (2007) Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 65(11):469–489CrossRefPubMed
25.
Zurück zum Zitat Aller R, Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, Fuente B, Gonzalez J (2011) Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15(9):1090–1095PubMed Aller R, Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, Fuente B, Gonzalez J (2011) Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15(9):1090–1095PubMed
26.
Zurück zum Zitat Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M (2008) Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (Fayetteville NY) 42(8):675–682. doi:10.1016/j.alcohol.2008.08.006 CrossRef Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M (2008) Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (Fayetteville NY) 42(8):675–682. doi:10.​1016/​j.​alcohol.​2008.​08.​006 CrossRef
27.
Zurück zum Zitat Wolf BW, Wheeler KB, Ataya DG, Garleb KA (1998) Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol 36(12):1085–1094CrossRefPubMed Wolf BW, Wheeler KB, Ataya DG, Garleb KA (1998) Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol 36(12):1085–1094CrossRefPubMed
28.
Zurück zum Zitat Ziada DH, Soliman HH, Yamany SA, Hamisa MF, Hasan AM (2013) Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy. Arab J Gastroenterol 14(3):116–122. doi:10.1016/j.ajg.2013.08.002 CrossRefPubMed Ziada DH, Soliman HH, Yamany SA, Hamisa MF, Hasan AM (2013) Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy. Arab J Gastroenterol 14(3):116–122. doi:10.​1016/​j.​ajg.​2013.​08.​002 CrossRefPubMed
29.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed
30.
Zurück zum Zitat van Rosendal SP, Osborne MA, Fassett RG, Coombes JS (2010) Guidelines for glycerol use in hyperhydration and rehydration associated with exercise. Sports Med 40(2):113 – 39CrossRefPubMed van Rosendal SP, Osborne MA, Fassett RG, Coombes JS (2010) Guidelines for glycerol use in hyperhydration and rehydration associated with exercise. Sports Med 40(2):113 – 39CrossRefPubMed
31.
Zurück zum Zitat Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 343:d5928. doi:10.1136/bmj.d5928 CrossRef Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 343:d5928. doi:10.​1136/​bmj.​d5928 CrossRef
32.
Zurück zum Zitat Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions, vol 5. Wiley Online Library Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions, vol 5. Wiley Online Library
33.
Zurück zum Zitat Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, Chan HL (2013) Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 12(2):256–262PubMed Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, Chan HL (2013) Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 12(2):256–262PubMed
34.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
35.
37.
Zurück zum Zitat Minelli EB, Benini A (2008) Relationship between number of bacteria and their probiotic effects. Microb Ecol Health Dis 20(4):180–183CrossRef Minelli EB, Benini A (2008) Relationship between number of bacteria and their probiotic effects. Microb Ecol Health Dis 20(4):180–183CrossRef
39.
Zurück zum Zitat Irwin C, Khalesi S, Cox AJ, Grant G, Davey AK, Bulmer AC, Desbrow B (2017) Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a Pilot Study. Eur J Nutr. doi:10.1007/s00394-017-1437-8 CrossRefPubMed Irwin C, Khalesi S, Cox AJ, Grant G, Davey AK, Bulmer AC, Desbrow B (2017) Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a Pilot Study. Eur J Nutr. doi:10.​1007/​s00394-017-1437-8 CrossRefPubMed
40.
Zurück zum Zitat Cox AJ, West NP, Horn PL, Lehtinen MJ, Koerbin G, Pyne DB, Lahtinen SJ, Fricker PA, Cripps AW (2014) Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults. Eur J Clin Nutr 68(11):1255–1257. doi:10.1038/ejcn.2014.137 CrossRefPubMed Cox AJ, West NP, Horn PL, Lehtinen MJ, Koerbin G, Pyne DB, Lahtinen SJ, Fricker PA, Cripps AW (2014) Effects of probiotic supplementation over 5 months on routine haematology and clinical chemistry measures in healthy active adults. Eur J Clin Nutr 68(11):1255–1257. doi:10.​1038/​ejcn.​2014.​137 CrossRefPubMed
41.
Zurück zum Zitat Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology (Baltimore Md) 39(5):1441–1449. doi:10.1002/hep.20194 CrossRef Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology (Baltimore Md) 39(5):1441–1449. doi:10.​1002/​hep.​20194 CrossRef
42.
Zurück zum Zitat Nabavi S, Rafraf M, Somi MH, Homayouni-Rad A, Asghari-Jafarabadi M (2014) Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 97(12):7386–7393. doi:10.3168/jds.2014-8500 CrossRefPubMed Nabavi S, Rafraf M, Somi MH, Homayouni-Rad A, Asghari-Jafarabadi M (2014) Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 97(12):7386–7393. doi:10.​3168/​jds.​2014-8500 CrossRefPubMed
44.
Zurück zum Zitat Horvath A, Leber B, Schmerboeck B, Tawdrous M, Zettel G, Hartl A, Madl T, Stryeck S, Fuchs D, Lemesch S, Douschan P, Krones E, Spindelboeck W, Durchschein F, Rainer F, Zollner G, Stauber RE, Fickert P, Stiegler P, Stadlbauer V (2016) Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther 44(9):926–935. doi:10.1111/apt.13788 CrossRefPubMedPubMedCentral Horvath A, Leber B, Schmerboeck B, Tawdrous M, Zettel G, Hartl A, Madl T, Stryeck S, Fuchs D, Lemesch S, Douschan P, Krones E, Spindelboeck W, Durchschein F, Rainer F, Zollner G, Stauber RE, Fickert P, Stiegler P, Stadlbauer V (2016) Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther 44(9):926–935. doi:10.​1111/​apt.​13788 CrossRefPubMedPubMedCentral
46.
47.
Zurück zum Zitat Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, Acquaviva R, Mastrojeni S, Malaguarnera G, Mistretta A, Li Volti G, Galvano F (2012) Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 57(2):545–553. doi:10.1007/s10620-011-1887-4 CrossRefPubMed Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, Acquaviva R, Mastrojeni S, Malaguarnera G, Mistretta A, Li Volti G, Galvano F (2012) Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 57(2):545–553. doi:10.​1007/​s10620-011-1887-4 CrossRefPubMed
48.
Zurück zum Zitat Firouzi S, Mohd-Yusof B-N, Majid H-A, Ismail A, Kamaruddin N-A (2015) Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial. BMC Complement Altern Med 15:1–10. doi:10.1186/s12906-015-0952-5 CrossRef Firouzi S, Mohd-Yusof B-N, Majid H-A, Ismail A, Kamaruddin N-A (2015) Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial. BMC Complement Altern Med 15:1–10. doi:10.​1186/​s12906-015-0952-5 CrossRef
49.
Zurück zum Zitat Lefevre M, Racedo SM, Denayrolles M, Ripert G, Desfougeres T, Lobach AR, Simon R, Pelerin F, Justen P, Urdaci MC (2017) Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans. Regul Toxicol Pharmacol RTP 83:54–65. doi:10.1016/j.yrtph.2016.11.010 CrossRefPubMed Lefevre M, Racedo SM, Denayrolles M, Ripert G, Desfougeres T, Lobach AR, Simon R, Pelerin F, Justen P, Urdaci MC (2017) Safety assessment of Bacillus subtilis CU1 for use as a probiotic in humans. Regul Toxicol Pharmacol RTP 83:54–65. doi:10.​1016/​j.​yrtph.​2016.​11.​010 CrossRefPubMed
50.
Zurück zum Zitat Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay-Cohen Y (2011) Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition (Burbank Los Angeles County Calif) 27(2):177–181. doi:10.1016/j.nut.2010.01.006 CrossRef Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay-Cohen Y (2011) Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition (Burbank Los Angeles County Calif) 27(2):177–181. doi:10.​1016/​j.​nut.​2010.​01.​006 CrossRef
51.
Zurück zum Zitat Kwak DS, Jun DW, Seo JG, Chung WS, Park S-E, Lee KN, Khalid-Saeed W, Lee HL, Lee OY, Yoon BC, Choi HS (2014) Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease. Eur J Gastroenterol Hepatol 26(12):1353–1359. doi:10.1097/MEG.0000000000000214 CrossRefPubMed Kwak DS, Jun DW, Seo JG, Chung WS, Park S-E, Lee KN, Khalid-Saeed W, Lee HL, Lee OY, Yoon BC, Choi HS (2014) Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease. Eur J Gastroenterol Hepatol 26(12):1353–1359. doi:10.​1097/​MEG.​0000000000000214​ CrossRefPubMed
52.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 17(1):1–12CrossRefPubMed Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 17(1):1–12CrossRefPubMed
55.
Zurück zum Zitat Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR (2005) Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 51(1):102–109. doi:10.1207/s15327914nc5101_14 CrossRefPubMed Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR (2005) Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 51(1):102–109. doi:10.​1207/​s15327914nc5101_​14 CrossRefPubMed
57.
Zurück zum Zitat Berg RD, Garlington AW (1979) Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23(2):403–411PubMedPubMedCentral Berg RD, Garlington AW (1979) Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23(2):403–411PubMedPubMedCentral
62.
63.
Zurück zum Zitat Konickova R, Jiraskova A, Zelenka J, Leseticky L, Sticha M, Vitek L (2012) Reduction of bilirubin ditaurate by the intestinal bacterium Clostridium perfringens. Acta Biochim Pol 59(2):289–92PubMed Konickova R, Jiraskova A, Zelenka J, Leseticky L, Sticha M, Vitek L (2012) Reduction of bilirubin ditaurate by the intestinal bacterium Clostridium perfringens. Acta Biochim Pol 59(2):289–92PubMed
64.
Zurück zum Zitat Gasteyger C, Larsen TM, Vercruysse F, Astrup A (2008) Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr 87(5):1141–1147CrossRefPubMed Gasteyger C, Larsen TM, Vercruysse F, Astrup A (2008) Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr 87(5):1141–1147CrossRefPubMed
65.
Zurück zum Zitat Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero-Romero F (2011) Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. Ann Hepatol 10 (4):486–92 Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero-Romero F (2011) Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. Ann Hepatol 10 (4):486–92
Metadaten
Titel
Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis
verfasst von
Saman Khalesi
David Wayne Johnson
Katrin Campbell
Susan Williams
Andrew Fenning
Sonia Saluja
Christopher Irwin
Publikationsdatum
08.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 6/2018
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-017-1568-y

Weitere Artikel der Ausgabe 6/2018

European Journal of Nutrition 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.